investordatabase.org

Syncona

synconaltd.com Direct investor

Syncona is a Guernsey-registered, London-listed life science company whose investment manager, Syncona Investment Management Limited, builds and manages a portfolio of life science companies across clinical stages. It was founded by the Wellcome Trust in 2012 and funds its portfolio from its own balance sheet.

Syncona is an asset manager headquartered in London, United Kingdom, founded in 2012. It invests directly in companies, from seed to growth, in life science, biotech and therapeutics. 15 portfolio companies, as it reports.

“Our Investment Manager has created a portfolio of life science companies and is investing in and managing these companies to deliver key value inflection points”

— Syncona, own website
Layer
Direct investor
Type
Asset manager
Stage
Seed – Growth
Headquarters
London, United Kingdom
Invests in
UK
Sectors
life science, biotech, therapeutics
Founded
2012
Portfolio
15 companies

Team, as Syncona publishes it

  • Chris Hollowood Chief Executive Officer and Chief Investment Officer
  • Kenneth Galbraith Chair of SIML and Executive Partner
  • Kate Butler Chief Financial Officer
  • Edward Hodgkin Managing Partner
  • Elisa Petris Managing Partner
  • Gonzalo Garcia Partner
  • Gwenaelle Pemberton Executive Partner
  • Hitesh Thakrar Executive Partner
  • Paul Sekhri Executive Partner
  • Richard Wooster Executive Partner
  • Roel Bulthuis Executive Partner
  • Samantha Roberts Managing Director

Names and roles exactly as listed on synconaltd.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Syncona publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 20270 · added 2026-10-27 · link last verified 2026-10-27 · confidence high

Similar investors

Listed under